Cargando…
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells
BACKGROUND: Paclitaxel, a widely used chemotherapeutic drug, can induce apoptosis in variety of cancer cells. A previous study has shown preferential toxicity of paclitaxel to FLCN-deficient kidney cancer cell line, UOK257. In this report, we investigate the cellular and molecular mechanism of pacli...
Autores principales: | Zhang, Qi, Si, Shuhui, Schoen, Sue, Chen, Jindong, Jin, Xun-Bo, Wu, Guan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879005/ https://www.ncbi.nlm.nih.gov/pubmed/24305604 http://dx.doi.org/10.1186/1756-9966-32-99 |
Ejemplares similares
-
Folliculin Contributes to VHL Tumor Suppressing Activity in Renal Cancer through Regulation of Autophagy
por: Bastola, Prabhat, et al.
Publicado: (2013) -
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015) -
Folliculin Regulates Ampk-Dependent Autophagy and Metabolic Stress Survival
por: Possik, Elite, et al.
Publicado: (2014) -
Folliculin mutations are not associated with severe COPD
por: Cho, Michael H, et al.
Publicado: (2008) -
Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells
por: Chen, Zhizhao, et al.
Publicado: (2020)